Equipment Holding Company K.S.C.P. (KWSE:EQUIPMENT)

Ligand Pharmaceuticals Balance Sheet

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Property, Plant & Equipment	3.26	3.26	3.29	3.44	11.38	11.51
Cash & Equivalents	0.88	0.95	1.21	1.06	1.17	1.16
Accounts Receivable	1.19	1.19	2.79	4.78	5.25	5.22
Other Current Assets	0.17	0.16	0.18	6.51	0.13	0.49
Trading Asset Securities	-	-	-	-	-	0.06
Other Long-Term Assets	0.51	0.51	0.62	0.62	0.81	0.81
Total Assets	6	6.08	8.09	16.4	18.73	19.24
Current Portion of Long-Term Debt	0.1	0.1	1.24	6.35	6.35	2.29
Long-Term Debt	0.3	0.3	-	-	-	4.03
Accounts Payable	1.57	1.58	1.58	2.39	2.79	2.48
Accrued Expenses	0.59	0.63	0.6	1.68	1.68	0.41
Current Unearned Revenue	-	-	-	0	0.04	0.03
Other Current Liabilities	0.7	0.7	0.34	0.18	2.16	2.65
Total Liabilities	3.29	3.34	4.52	11.83	13.72	13.54
Common Stock	8	8	8	8	8	8
Retained Earnings	-5.6	-5.58	-4.76	-3.73	-3.27	-2.55
Comprehensive Income & Other	0.31	0.32	0.33	0.3	0.28	0.25
Shareholders' Equity	2.71	2.74	3.57	4.57	5.01	5.7
Total Liabilities & Equity	6	6.08	8.09	16.4	18.73	19.24
Total Debt	0.43	0.43	2.01	7.57	7.04	7.04
Net Cash (Debt)	0.45	0.52	-0.8	-6.52	-5.88	-5.82
Net Cash Per Share	0.01	0.01	-0.01	-0.08	-0.07	-0.07
Filing Date Shares Outstanding	80	80	80	80	80	80
Total Common Shares Outstanding	80	80	80	80	80	80
Book Value Per Share	0.03	0.03	0.04	0.06	0.06	0.07
Tangible Book Value	2.71	2.74	3.57	4.57	5.01	5.7
Tangible Book Value Per Share	0.03	0.03	0.04	0.06	0.06	0.07
Buildings	-	0.39	0.39	0.36	0.33	0.3

Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.